PRESTIGE CONSUMER HEALTHCARE INC.

Analyst Reco. Prestige Consumer Healthcare Inc.

Equities

PBH

US74112D1019

Real-time Estimate Cboe BZX Other stock markets 01:41:47 2024-05-13 pm EDT			5-day change	1st Jan Change
70.4 ^USD	+0.02%		+0.53%	+14.95%

Feb. 16	Prestige Consumer Healthcare Insider Sold Shares Worth $1,766,665, According to a Recent SEC Filing	MT
Feb. 16	Prestige Consumer Healthcare Insider Sold Shares Worth $2,051,874, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Adjusts Prestige Consumer Healthcare's Price Target to $71 From $72, Maintains Outperform Rating	23-02-17	MT
Canaccord Genuity Starts Prestige Consumer Healthcare at Buy With $71 Price Target	22-11-17	MT
Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $63 From $68, Maintains Outperform Rating	22-09-27	MT
Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $68 From $63, Maintains Outperform Rating	22-08-01	MT
ANALYST RECOMMENDATIONS : Edison International, Ford, General Motors, GSK, Upstart...	22-05-10
Jefferies Upgrades Prestige Consumer Healthcare to Buy From Hold, Adjusts Price Target to $70 From $65	22-05-10	MT
DA Davidson Lowers Prestige Consumer Healthcare's Price Target to $60 From $63, Maintains Neutral Rating	22-05-09	MT
Oppenheimer Upgrades Prestige Consumer Healthcare to Outperform From Perform, Sets $63 Price Target	22-05-09	MT
DA Davidson Adjusts Price Target on Prestige Consumer Healthcare to $63 from $61, Keeps Neutral Rating	21-11-15	MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $61 from $52, Keeps Neutral Rating	21-08-06	MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $52 from $49, Keeps Neutral Rating	21-05-28	MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $49 from $39, Keeps Neutral Rating	21-05-10	MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $39 from $45, Maintains Neutral Rating	20-11-06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW